Statin Landmark Trials Across the Spectrum of Risk: Primary CV Prevention

Slide lecture program (8 slides): View & Download

1. Over Time Additional Risk Factors CanProgress
2. ASCOT LLA Trial of Statin in Hypertensive Patients With Additional Risk Factors
3. ASCOT LLA Primary End Point: Nonfatal MI and Fatal CHD
4. ASCOT LLA Secondary End Point: Fataland Nonfatal Stroke
5. HPS: Effects of Statin on Major Coronary Events and Stroke in Diabetic andNondiabetic Patients
6. CARDS: Effect of Atorvastatin on thePrimary End Point—Major CV EventsIncluding Stroke
7. CARDS: Component End Points
8. JUPITER Trial of Statin in People With Elevated CRP: Primary End Point

Click on slides to preview

Download slides below

634918750768267500-Download slides CV risk and lipid management. section 3 (PPTX 407KB)

Statin Landmark Trials Across the Spectrum of Risk	Over Time Additional Risk Factors CanProgress
ASCOT LLA Trial of Statin in Hypertensive Patients	ASCOT LLA Primary End Point:Nonfatal MI and Fatal CHD
ASCOT LLA Secondary End Point: Fataland Nonfatal Stroke	HPS: Effects of Statin on Major Coronary Events and Stroke
CARDS: Effect of Atorvastatin on thePrimary End Point	CARDS: Component End Points
JUPITER Trial of Statin in People WithElevated CRP